Skip to content

PRESS RELEASES


PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary Integra LifeSciences to Present at Healthcare Conferences in June 2017
PLAINSBORO, N.J., May 24, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that it will present at the following conferences in June: At 4:00PM ET on Wednesday, June 7, 2017, Mr.
View HTML
Toggle Summary Integra LifeSciences Announces Agreement with aap to Distribute LOQTEQ® Distal Radius System
PLAINSBORO, N.J. and BERLIN, May 23, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation  (Nasdaq:IART), a leading global medical technology company, announced today that it has signed an agreement with aap Implantate AG (" aap ") to distribute the LOQTEQ® Distal Radius System within
View HTML
Toggle Summary Integra LifeSciences Announces the European Launch of Integra® Dermal Regeneration Template Single Layer "Thin"
PLAINSBORO, N.J., May 17, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation  (Nasdaq:IART), a leading global medical technology company, today announced that it has launched in Europe Integra ®  Dermal Regeneration Template (IDRT) Single Layer "Thin" for dermal repair defects
View HTML
Toggle Summary Integra LifeSciences launches SurgiMend® MP Collagen Matrix for Hernia Repair
SurgiMend MP is a collagen matrix for soft tissue reconstruction, featuring a highly macroporous design
View HTML
Toggle Summary Integra LifeSciences to Present at Healthcare Conferences in May 2017
PLAINSBORO, N.J., May 03, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that it will present at the following conferences in May: At 10:40AM PT on Tuesday, May 16, 2017, Mr.
View HTML
Toggle Summary Integra LifeSciences Reports First Quarter 2017 Financial Results
Revenue Increased 9.2% to $258.6 million; Organic Revenue Increased 6.4%  Reported EPS of $0.08; Adjusted EPS of $0.39 PLAINSBORO, N.J., April 26, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today reported its
View HTML
Toggle Summary Integra LifeSciences to Host Its First Quarter 2017 Earnings Results Conference Call on April 26, 2017
PLAINSBORO, N.J., April 12, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, will release its first quarter 2017 financial results on Wednesday, April 26, 2017. The company has scheduled a conference call for 8:30 AM ET
View HTML
Toggle Summary Integra LifeSciences Announces Expansion of Credit Facility to include new $700 million term loan
Financing now secured for the planned acquisition of Codman Neurosurgery
View HTML
Toggle Summary Integra LifeSciences Announces Commercial Expansion of the Cadence® Total Ankle System
PLAINSBORO, N.J., March 28, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced full commercial availability of its Cadence ® Total Ankle System, a new ankle prosthesis developed in partnership with four
View HTML
Toggle Summary Integra LifeSciences Introduces Next Generation CUSA® Clarity Ultrasonic Tissue Ablation System
PLAINSBORO, N.J., March 16, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a global leader in medical technology, announces the launch of its new CUSA® Clarity ultrasonic tissue ablation platform designed to deliver an innovative, integrated system for enhanced
View HTML
Toggle Summary Integra LifeSciences Launches Press-Fit Reverse Shoulder for Fracture for the Titan™ Modular Shoulder System
PLAINSBORO, N.J., March 15, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation   (Nasdaq:IART), a leading global medical technology company, announced the launch of the Titan™ Press-Fit Reverse Shoulder for Fracture. The use of the reverse shoulder to treat humeral fractures has
View HTML
Toggle Summary Integra LifeSciences to Present at the Barclays Global Healthcare Conference and Oppenheimer's 27th Annual Healthcare Conference in March 2017
PLAINSBORO, N.J., Feb. 28, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it will present at the following conferences in March: At 9:00AM ET on Tuesday, March 14, 2017, Mr. Glenn Coleman, Chief Financial Officer and Corporate VP of
View HTML
Toggle Summary Integra LifeSciences Announces Acceptance of Shares Tendered into Offer for Derma Sciences, Inc.
PLAINSBORO, N.J., Feb. 23, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation ("Integra") (NASDAQ:IART), a global leader in medical technology, announced today that its tender offer by its wholly-owned subsidiary, Integra Derma, Inc. ("Offeror"), to purchase all outstanding common
View HTML
Toggle Summary Integra LifeSciences Reports Fourth Quarter and Full-Year 2016 Financial Results and Updates 2017 Full-Year Guidance
2016 Results and 2017 Guidance in line with January 10, 2017 Preliminary Announcement
View HTML
Toggle Summary Integra LifeSciences Plans to Acquire the Codman Neurosurgery Business from Johnson & Johnson for $1.045 Billion in Cash
Enhances global position in neurosurgery by adding a complementary product portfolio and the world-recognized Codman brand Builds relevant scale, accelerates international growth and expands the neurosurgery sales channel Accelerates Integra's strategy to achieve aspirational targets of $2 billion
View HTML